DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES

The contract SPE2DP26F7909, awarded on July 21, 2026, to DMS PHARMACEUTICAL GROUP INC (CAGE 1UNB0), is a single-line-item delivery order under the base contract SPE2DX25D9900 for one bottle of DIPHENHYDRAMINE HYDROCHLORIDE CAPSULES (NSN 6505011533272) at a total price of $3.19. The procurement is administered by the Defense Logistics Agency through its Medical Supply Chain FSB in Philadelphia, with payment processed by the Defense Finance and Accounting Service in Columbus, Ohio. The contract was issued as a commercial item acquisition under FAR Part 12, incorporating the standard clauses FAR 52.212-4 and FAR 52.212-5, and includes compliance requirements for combating trafficking in persons under FAR 52.222-50. Delivery is scheduled for August 5, 2026, to a military facility in Morrisville, North Carolina, under FOB Destination terms, meaning the contractor assumes all costs and risks until the goods reach the designated location. Shipping must be conducted via traceable methods, explicitly excluding parcel post, and the contractor is responsible for compliance with applicable National Drug Code identifiers and labeling standards, though no detailed packaging, marking, or barcoding requirements from military standards such as MIL-STD-129 or MIL-STD-2073 are specified. The solicitation was set aside for small business participation under NAICS code 325412, with no formal evaluation factors or award rationale disclosed in the available documentation. Payment is expected within 30 days of invoice submission to the designated remittance address, and the contract lacks any options, indefinite-delivery provisions, or modifications beyond the base IDIQ vehicle. The award amount of $3.19 reflects an actual transaction value, not a system placeholder, and the contract is executed under the SF 1449 format with administrative oversight provided by Catherine Gilbert, while no Contracting Officer’s Representative is named.